Skip to main content
Log in

Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) —literature review

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Objective

To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a replacement from SB in men at clinical risk of prostate cancer.

Methods

The non-systematic literature was searched for peer-reviewed English-language articles using PubMed, including the prospective paired studies, where the index test was MRI-TB and the comparator text was SB. Also the randomized clinical trials (RCTs) are included if one arm was MRI-TB and another arm was SB.

Results

Eighteen prospective studies used both MRI-TB and TRUS-SB, and eight RCT received one of the tests for prostate cancer detection. In most prospective trials to compare MRI-TB vs. SB, there was no significant difference in any cancer detection rate; however, MRI-TB detected more men with CSCa and fewer men with CISCa than SB.

Conclusion

MRI-TB is superior to SB in detection of CSCa. Since some significant cancer was detected by SB only, a combination of SB with the TB technique would avoid the underdiagnosis of CSCa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

COG-TB:

Cognitive fusion targeted biopsy

CSCa:

Clinically significant prostate cancer

CISCa:

Clinically insignificant prostate cancer

CDRs:

Cancer detection rates

GS:

Gleason score

PSA:

Prostatic-specific antigen

RCT:

Randomized controlled trial

SB:

Systematic biopsy

TB:

Targeted biopsy

TRUS:

Transrectal ultrasonography

MRI:

Magnetic resonance imaging

MRUS:

Magnetic resonance ultrasonography

References

  1. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45(1):2–12

    Article  CAS  Google Scholar 

  2. de la Rosette JJ, Wink MH, Mamoulakis C et al (2009) Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol. J Urol 182(4):1329–1336. https://doi.org/10.1016/j.juro.2009.06.037

    Article  PubMed  Google Scholar 

  3. Lui PD, Terris MK, Mcneal JE et al (1995) Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 153(3 Pt 2):1000–1003

    CAS  PubMed  Google Scholar 

  4. Djavan B, Ravery V, Dobronski P et al (2001) Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166(5):1679–1683

    Article  CAS  Google Scholar 

  5. Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM (2015) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy : a systematic review and meta-analysis. Eur Urol 68(3):438–450. https://doi.org/10.1016/j.eururo.2014.11.037

    Article  PubMed  Google Scholar 

  6. Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Novara G (2019) Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis. Eur Urol. https://doi.org/10.1016/j.eururo.2019.04.043

    Article  PubMed  Google Scholar 

  7. Da Rosa MR, Milot L, Sugar L et al (2015) A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 41(1):220–225. https://doi.org/10.1002/jmri.24710

    Article  PubMed  Google Scholar 

  8. Diaz AW, Hoang AN, Turkbey B et al (2020) Can magnetic resonance-ultrasound fusion biopsy improve. J Urol 190(6):2020–2025. https://doi.org/10.1016/j.juro.2013.05.118

    Article  Google Scholar 

  9. Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67(4):787–794. https://doi.org/10.1016/j.eururo.2014.08.077

    Article  PubMed  Google Scholar 

  10. Rastinehad AR, Turkbey B, Salami SS et al (2014) Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 191(6):1749–1754. https://doi.org/10.1016/j.juro.2013.12.007

    Article  PubMed  Google Scholar 

  11. Delongchamps NB, Portalez D, Bruguière E et al (2016) Are MRI-TRUS-guided targeted biopsies non-inferior to TRUS-guided systematic biopsies for the detection of prostate cancer in patients with a single suspicious focus on multiparametric prostate MRI? Results of a multicentric controlled trial. J Urol. https://doi.org/10.1016/j.juro.2016.04.003

    Article  PubMed  Google Scholar 

  12. Borkowetz A, Platzek I, Toma M et al (2015) Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int 116(6):873–879. https://doi.org/10.1111/bju.13023

    Article  PubMed  Google Scholar 

  13. Rosario DJ, Walton TJ, Kennish SJ (2018) In-bore multiparametric magnetic resonance imaging targeted biopsy: as good as it gets? Eur Urol 75(4):579–581. https://doi.org/10.1016/j.eururo.2018.12.001

    Article  PubMed  Google Scholar 

  14. Lee DJ, Recabal P, Sjoberg DD et al (2016) Comparative effectiveness of targeted prostate biopsy using MRI-US fusion software and visual targeting: a prospective study. J Urol. https://doi.org/10.1016/j.juro.2016.03.149

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wegelin O, van Melick HHE, Hooft L, Bosch JLHR, Reitsma HB, Barentsz JO, Somford DM (2017) Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 71(4):517–531. https://doi.org/10.1016/j.eururo.2016.07.041

    Article  PubMed  Google Scholar 

  16. Yamada Y, Fujihara A, Shiraishi T et al (2019) Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: initial experience in Japan. Int J Urol. https://doi.org/10.1111/iju.13924

    Article  PubMed  Google Scholar 

  17. Ukimura O, Marien A, Palmer S et al (2015) Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies. World J Urol. https://doi.org/10.1007/s00345-015-1501-z

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ukimura O, Desai MM, Palmer S et al (2012) 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 187(3):1080–1086. https://doi.org/10.1016/j.juro.2011.10.124

    Article  PubMed  Google Scholar 

  19. Study PM, Leroy X, Comperat E (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy —prospective multicentre study. Radiology 268(2):461–469. https://doi.org/10.1148/radiol.13121501/-/DC1

    Article  Google Scholar 

  20. Kuru TH, Roethke MC, Seidenader J et al (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190(4):1380–1386. https://doi.org/10.1016/j.juro.2013.04.043

    Article  PubMed  Google Scholar 

  21. Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66(2):343–351. https://doi.org/10.1016/j.eururo.2013.10.048

    Article  PubMed  Google Scholar 

  22. Sonn GA, Chang E, Natarajan S et al (2014) Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 65(4):809–815. https://doi.org/10.1016/j.eururo.2013.03.025

    Article  PubMed  Google Scholar 

  23. Mozer P, Rouprêt M, Le CC et al (2015) First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int 115(1):50–57. https://doi.org/10.1111/bju.12690

    Article  CAS  PubMed  Google Scholar 

  24. Quentin M, Blondin D, Arsov C et al (2014) Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy na €ıve men with elevated prostate specific antigen. J Urol 192:1374–1379. https://doi.org/10.1016/j.juro.2014.05.090

    Article  PubMed  Google Scholar 

  25. Passoni M, Polascik TJ, Parkinson R et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29. https://doi.org/10.1016/j.eururo.2014.03.002

    Article  Google Scholar 

  26. Maxeiner A, Stephan C, Durmus T, Slowinski T, Cash H, Fischer T (2015) Added value of multiparametric ultrasonography in magnetic resonance. Urology 86(1):108–114. https://doi.org/10.1016/j.urology.2015.01.055

    Article  PubMed  Google Scholar 

  27. Peyronnet B, De GA, Roupr M et al (2015) Oncology: prostate/testis/penis/urethra accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinically significant prostate cancer in enlarged compared to smaller prostates. J Urol. https://doi.org/10.1016/j.juro.2015.03.025

    Article  PubMed  Google Scholar 

  28. Mendhiratta N, Rosenkrantz AB, Meng X et al (2015) Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification. J Urol 194(6):1601–1606. https://doi.org/10.1016/j.juro.2015.06.078

    Article  PubMed  Google Scholar 

  29. Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397. https://doi.org/10.1001/jama.2014.17942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Filson CP, Natarajan S, Margolis DJA, Huang J, Lieu P (2016) Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer. https://doi.org/10.1002/cncr.29874

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rouvi O, Delongchamps NB, Portalez D et al (2016) Are magnetic resonance imaging-transrectal ultrasound guided targeted biopsies noninferior to transrectal ultrasound guided systematic biopsies for the detection of prostate cancer? J Urol 196:1069–1075. https://doi.org/10.1016/j.juro.2016.04.003

    Article  Google Scholar 

  32. Jelidi A, Ohana M, Labani A, Alemann G, Lang H, Roy C (2017) Prostate cancer diagnosis: efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies. Eur J Radiol 86:127–134. https://doi.org/10.1016/j.ejrad.2016.11.016

    Article  PubMed  Google Scholar 

  33. Paper O (2017) Urologia a prospective comparison of selective multiparametric magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsies for detecting prostate cancer in men undergoing repeated biopsies. Urol Int 99(4):384–391. https://doi.org/10.1159/000477214

    Article  Google Scholar 

  34. Rouvière O, Puech P, Renard-penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20(1):100–109. https://doi.org/10.1016/S1470-2045(18)30569-2

    Article  PubMed  Google Scholar 

  35. Elkhoury FF, Feller ER, Kwan L et al (2019) Comparison of targeted vs. systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAREDCAP) Study. JAMA Surg 154(9):811–818. https://doi.org/10.1001/jamasurg.2019.1734

    Article  PubMed  PubMed Central  Google Scholar 

  36. Kuru TH, Roethke MC, Seidenader J et al (2013) New technology and techniques critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190:1380–1386. https://doi.org/10.1016/j.juro.2013.04.043

    Article  PubMed  Google Scholar 

  37. Park BK, Park JW, Park SY et al (2011) Genitourinary imaging original research. Am J Radiol. https://doi.org/10.2214/AJR.11.6829

    Article  Google Scholar 

  38. Arsov C, Rabenalt R, Blondin D et al (2015) Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 68:713–720. https://doi.org/10.1016/j.eururo.2015.06.008

    Article  PubMed  Google Scholar 

  39. Baco E, Rud E, Magne L et al (2016) A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69(1):149–156. https://doi.org/10.1016/j.eururo.2015.03.041

    Article  PubMed  Google Scholar 

  40. Taverna G, Bozzini G, Grizzi F et al (2016) Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial. World J Urol 34(6):797–803. https://doi.org/10.1007/s00345-015-1711-4

    Article  PubMed  Google Scholar 

  41. Panebianco V, Barchetti F et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33(1):17.e1–17.e7. https://doi.org/10.1016/j.urolonc.2014.09.013

    Article  Google Scholar 

  42. Piippo U, Kauppila S, Tonttila PP et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69:419–425. https://doi.org/10.1016/j.eururo.2015.05.024

    Article  PubMed  Google Scholar 

  43. Porpiglia F, Manfredi M, Mele F et al (2017) Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer. Eur Urol 72(2):282–288. https://doi.org/10.1016/j.eururo.2016.08.041

    Article  PubMed  Google Scholar 

  44. Kassivisvanathan V, Ranniko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378(19):1767–1777. https://doi.org/10.1056/NEJMoa1801993

    Article  Google Scholar 

  45. Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–42. https://doi.org/10.1111/bju.12637

    Article  PubMed  Google Scholar 

  46. Wegelin O, Exterkate L, Van der Leest M et al (2019) Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the FUTURE trial, a multicentre randomised controlled trial. Eur Urol Oncol 2(6):617–624. https://doi.org/10.1016/j.euo.2019.08.007

    Article  PubMed  Google Scholar 

  47. Connor MJ, Eldred-Evans D, van Son M et al (2020) A multicentre study of the clinical utility of non-targeted systematic transperineal prostate biopsies in patients undergoing pre-biopsy mpMRI. J Urol. https://doi.org/10.1097/JU.0000000000001184

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Osamu Ukimura.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, Y., Ukimura, O., Kaneko, M. et al. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) —literature review. World J Urol 39, 677–686 (2021). https://doi.org/10.1007/s00345-020-03366-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-020-03366-x

Keywords

Navigation